Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Japan Lifeline Co's share price for the quarter that ended in Dec. 2023 was 円1263. Japan Lifeline Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 75 Mil. Therefore, Japan Lifeline Co's market cap for the quarter that ended in Dec. 2023 was 円95,182 Mil.
Japan Lifeline Co's quarterly market cap
increased
from Jun. 2023 (円79,585 Mil) to Sep. 2023 (円88,560 Mil) and
increased
from Sep. 2023 (円88,560 Mil) to Dec. 2023 (円95,182 Mil).
Japan Lifeline Co's annual market cap
declined
from Mar. 2022 (円82,077 Mil) to Mar. 2023 (円71,375 Mil) but then
increased
from Mar. 2023 (円71,375 Mil) to Mar. 2024 (円91,339 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Japan Lifeline Co's Enterprise Value for Today is 円76,790 Mil.
Japan Lifeline Co Market Cap Historical Data
The historical data trend for Japan Lifeline Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Japan Lifeline Co's Market Cap
For the Medical Devices subindustry, Japan Lifeline Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's Market Cap falls into.
Japan Lifeline Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Japan Lifeline Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Lifeline Co (TSE:7575) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Japan Lifeline Co Market Cap Related Terms
Thank you for viewing the detailed overview of Japan Lifeline Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7575 has been successfully added to your 